We are a leading Manufacturer of piroxicam 20 mg dispersible tablet, febuxostat 40 mg tablets and tofacitinib 5 mg tablets from Ambala, India.
โน 1400 / Box Get Latest Price
| Strength | 20mg |
| Release Type | Dispersible |
| Brand | PIROVIX-20 DT |
| Packaging Size | 10*10 |
| Usage | Rheumatoid Arthritis |
| Packaging Type | Box |
| Prescription Type | Prescription |
| Shelf Life | 24 months |
| Also Gives | PCD Pharma Franchise, Third Party Manufacturing |
features of Piroxicam 20 mg Dispersible Tablet (a formulation of the NSAID piroxicam designed to dissolve easily in water for oral use):
๐งช 1. Active IngredientContains Piroxicam 20 mg, a non-steroidal anti-inflammatory drug (NSAID) used for pain and inflammation relief.
Designed to dissolve quickly in water before swallowing, making it easier to take — especially for people who have trouble swallowing standard tablets.
Faster dissolution can help speed up absorption and onset of action.
Works by inhibiting cyclooxygenase (COX-1 and COX-2) enzymes, which reduces the production of prostaglandins — chemicals in the body that cause pain, swelling, inflammation and fever.
Has anti-inflammatory, analgesic (pain-relieving) and antipyretic (fever-reducing) effects.
Due to its long duration of action, usually taken once a day or as directed by a physician.
It’s commonly prescribed for conditions involving pain and inflammation, including:
Osteoarthritis and rheumatoid arthritis (chronic joint disorders)
Ankylosing spondylitis
Musculoskeletal pain, strains and sprains
Post-surgical or dental pain
Other painful inflammatory conditions as advised by doctor
Can be taken with water or after dissolving in a small amount of water.
Usually recommended after food to reduce risk of stomach irritation.
โน 1260 / Box Get Latest Price
| Strength | 40mg |
| Brand | URIBUZ-40 |
| Usage | Rheumatoid Arthritis, Gout Attack, Osteoarthritis Arthritis |
| Form | Tablet |
| Packaging Size | 10*10 Tablets |
| Packaging Type | Box |
| Composition | Febuxostat 40mg |
| Shelf Life | 24 Months |
| Prescription/Non-Prescription | Prescription |
| Also Gives | PCD Pharma Franchise |
Febuxostat 40 mg Tablets are commonly prescribed to manage high uric acid levels and gout. Below are the key features (useful for product description or promotional material):
Features of Febuxostat 40 mg TabletsEffective Uric Acid Reduction
Febuxostat lowers serum uric acid levels by inhibiting the enzyme xanthine oxidase, which is responsible for producing uric acid in the body.
Management of Chronic Gout
It is mainly used for long-term treatment of chronic gout and hyperuricemia, helping prevent painful gout attacks.
Prevents Uric Acid Crystal Formation
By reducing uric acid levels, it prevents the formation and deposition of urate crystals in joints and tissues.
Helps Reduce Frequency of Gout Flares
Maintaining uric acid levels below the saturation point helps decrease the frequency and severity of gout flare-ups.
Non-Purine Selective Xanthine Oxidase Inhibitor
Febuxostat is a selective non-purine inhibitor, making it effective in lowering uric acid without interfering with other metabolic pathways.
Suitable Alternative to Allopurinol
Often prescribed for patients who cannot tolerate or do not respond well to allopurinol therapy.
Supports Joint Health
Long-term use helps reduce joint inflammation and may prevent joint damage caused by persistent urate crystal deposition.
Once-Daily Oral Therapy
Usually administered as a convenient once-daily tablet, improving patient compliance.
โ๏ธ Strength: 40 mg
โ๏ธ Dosage Form: Oral tablet
โ๏ธ Therapeutic Class: Antigout / Antihyperuricemic agent
โน 3800 / Box Get Latest Price
| Strength | 5 mg |
| Brand | TOFABAX-5 |
| Composition | Tofacitinib 5mg |
| Form | Tablet |
| Packaging Size | 10*10 Tablets |
| Packaging Type | Box |
| Usage | Rheumatoid arthritis |
| Shelf Life | 24 Months |
| Prescription Type | Prescription |
| Prescription/Non-Prescription | Prescription |
| Manufacturer | Other Manufacturer |
| Also Gives | PCD Pharma Franchise |
Features of Tofacitinib 5 mg Tablets
Janus Kinase (JAK) Inhibitor: Tofacitinib works by inhibiting JAK enzymes (mainly JAK1 and JAK3), which are involved in immune and inflammatory signaling pathways.
Reduces Inflammation: Helps decrease inflammatory cytokine activity, reducing swelling, pain, and stiffness in autoimmune diseases.
Disease-Modifying Action: Classified as a disease-modifying antirheumatic drug (DMARD) that helps slow disease progression and prevent joint damage.
Effective in Autoimmune Disorders: Commonly used in rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis when conventional therapy is inadequate.
Improves Physical Function: Helps improve mobility, joint function, and overall quality of life in patients with chronic inflammatory conditions.
Oral Administration: Available as a convenient oral tablet, making it easier compared with injectable biologic therapies.
Rapid Absorption: Achieves peak plasma levels within about 0.5–1 hour, providing quick systemic action.
Flexible Therapy: Can be used alone or with other DMARDs (e.g., methotrexate) depending on clinical requirements
VINAY GUPTA (CEO)
Realnova Healthcare
Plot No. 11/1, Arjun Nagar, Nanhera, Ambala Chawni
Ambala - 133001, Haryana, India